Robocath, a company that designs, develops and commercialises cardiovascular robotic systems for the treatment of vascular diseases, has announced that the Medical Training & Testing Centre (MTC) in Rouen will use its R-One robot for future training. Founded in 2017, the MTC is a new centre dedicated to training healthcare professionals in a number specialties, with special focus on new technologies.
Credit: Robocath
The R-On robot at the MTC will enable the training of future potential users and ensure optimal use by healthcare practitioners, ahead of the upcoming commercial launch of the device in Europe and the Middle East.
Philippe Bencteux, MD, president and founder of Robocath, said: “This acquisition by the MTC of our first robotic solution is a key step in our company’s development. I am particularly proud of this collaboration. We share the same goal: to contribute to a new era of medical advances where robotics will definitely play a critical role.”
Véronique Desjardins, general manager of Rouen University Hospital Centre, said: “The medical teams from the Rouen University Hospital Centre were closely involved in the design of the R-On robot, due to the proximity of Robocath’s headquarters. This collaborative work within the ‘Rouen Innovation Santé’ working group shows that local collaborations can result in promising innovations for the benefit of healthcare practitioners and patients.
"Thanks to the financial support from the Rouen Normandy Metropole, the Rouen University Hospital Centre was able to acquire the R-On device to complete MTC’s cutting-edge technical equipment offering. The robot will enable us to train future users of the platform. This fully aligns with our objective to support medical innovation and to bring these innovations to medical teams. Support for innovation and applied research is one of MTC’s goals, a centre that meets the needs of healthcare companies for testing of and training on the medical devices they develop."
Back to Homepage
Back to Healthcare